Carmell Therapeutics (CTCX) S-1 IPO registration

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT 

We consent to the inclusion in this Registration Statement of Carmell Corporation (the “Company”) to Form S-4 to be filed on May 10, 2024, of our report dated April 1, 2024, with respect to our audits of the consolidated financial statements of Carmell Corporation as of December 31, 2023 and 2022, and for the years then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

/s/ Adeptus Partners, LLC

Adeptus Partners, LLC

Ocean, New Jersey

May 10, 2024